Gabriel Vivó-Truyols from the Spanish Council for Scientific Research, Madrid, Spain. discusses his work on using graph theory and Bayesian statistics for peak assignment and chromatographic alignment.
|Articles|August 5, 2020
- The Column-08-06-2020
- Volume 16
- Issue 8
Vol 16 No 8 The Column August 2020 North American PDF
Click the link below to open The Column August 2020 North American issue, Volume 16, Number 8, in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Vol 16 No 8 The Column August 2020 Europe & Asia PDFover 6 years ago
Three-Dimensional Thinkingover 6 years ago
BIA Separations Announce Asia Distribution Dealsover 6 years ago
Contaminant Detection in Animal Feed using LC– and GC–MS/MSover 6 years ago
The Science of Inspiration: Post‑COVID-19Advertisement
Related to this article
Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
How can advanced separations, inert hardware, orthogonal methods, and AI solve key challenges in reliable GLP-1 peptide analysis workflows?
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Advertisement
Advertisement
Trending on LCGC International
1
LC–MS/MS Dried Blood Spot Test for Galactosemia
2
GLP-1 Peptide Analysis: Challenges and Solutions
3
AI/ML Now: Uncertainty-Driven Model-Based Search Methods for Method Development in Liquid Chromatography (Part One)
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5